Finder Energy Holdings Limited (ASX:FDR)

Australia flag Australia · Delayed Price · Currency is AUD
0.0800
+0.0030 (3.90%)
Aug 1, 2025, 4:10 PM AEST

Inozyme Pharma Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2020
Selling, General & Admin
0.90.80.80.75--
Upgrade
Other Operating Expenses
-9.44-0.02-2.66-1.2-1.56-1.69
Upgrade
Operating Expenses
-4.044.422.834.182.571.83
Upgrade
Operating Income
4.04-4.42-2.83-4.18-2.57-1.83
Upgrade
Interest & Investment Income
0.080.160.3300-
Upgrade
Currency Exchange Gain (Loss)
0.65---0.14-0.110
Upgrade
Other Non Operating Income (Expenses)
----0-
Upgrade
Pretax Income
4.76-4.26-2.5-4.32-2.68-1.83
Upgrade
Income Tax Expense
-0.02-0.02-0.021.95-0.67-0.49
Upgrade
Net Income
4.78-4.24-2.48-6.26-2.01-1.34
Upgrade
Net Income to Common
4.78-4.24-2.48-6.26-2.01-1.34
Upgrade
Shares Outstanding (Basic)
1931581589983-
Upgrade
Shares Outstanding (Diluted)
1931581589983-
Upgrade
Shares Change (YoY)
22.67%-58.56%20.40%--
Upgrade
EPS (Basic)
0.02-0.03-0.02-0.06-0.02-
Upgrade
EPS (Diluted)
0.02-0.03-0.02-0.06-0.02-
Upgrade
EBIT
4.04-4.42-2.83-4.18-2.57-1.83
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.